PF-07263689

N/A

Report date: 2023/02/26 16:30:42

Base Information

Drug NamePF-07263689
Drug Alias NamePF-07263689
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksN/A